What is Meropen?

Meropen is an antibiotic used to treat various bacterial infections. It is classified as a beta-lactam, a cyclic amid that has a molecular structure containing three carbon atoms and one nitrogen atom. As an antibiotic of beta-lactam, Meropen belongs to the drug class called carbapene, which are characterized by a wide range of antibacterial activity. As a result, it is similar to antibiotics such as Imipen and Ertapen. Meropen is also known as the names of the brand Carbon, Merre, Meron, Neuten and Zwipen. In particular, it is resistant to degradation of enzymes such as beta-lactamase, and it is a great penetrator of body fluids and tissues. Meropen is most often used to combat meningitis and pneumonia. These are inflammatory conditions that affect brain and spinal cord and lungs. Meropin is also used for bacterial bone, skin, urinary tract and stomach.

doctors are looking for large muscles such as hips or buttocks to insert the medicine. However, in some cases they can add a meroPenus into the case of intravenous (IV) fluid, allowing the antibiotics to pass into the patient's vein. Doctors apply Method IV for up to 15 minutes, one to three times a day.

those who plan to take by meropen must tell their doctors any allergies to pharmacies such as cephalexin, whose brand is keflex; Cefalosporins such as CEFAClor, CECLOR; Cefadroxil, Duricef brand; and penicillin. Doctors should also be informed if the patient suffers or suffers from kidney or liver disease. People who take Meropen can have some side effects. These include dry mouth, diarrhea, constipation, headache, digestive problems, inflammation of the injection site and stomach problems.

Meropen side effects include dizziness, fatigue, seizures and drowsiness. Any of these features require immediate medical care. Some cases of people with hypokalaemia or reduce the amount of potassium have been reportedEré is associated with the administration of Meropnema.

As far as legal status is concerned, Meropen is available as a prescription drug in the United States and the UK. In the first case, the drugs were approved by US food and drug administration (FDA) in 1996. The FDA will place it in category B its classification of the pharmaceutical risk of fetus. It is one of the milder FDA charts, so Meropen is a relatively low -aid drug for pregnant patients.